Kansas committee hears sharply divided testimony on HB2550 requiring 340B hospital reporting Supporters said HB2550 would add needed transparency to the federal 340B drug‑pricing program so policymakers can see whether savings reach vulnerable patients; hospitals and rural pharmacists called the measure duplicative, one‑sided and administratively burdensome.

Kansas hospitals are caught in a heated debate over a new bill that could change how drug pricing savings are reported, raising questions about transparency and patient care.

Read the full story

#KS #CitizenPortal #KansasHospitals #RuralHealthcareAccess #DrugPricingReform #HealthcareTransparency

Cost Plus Drug Company stresses transparency in pricing to combat pharmaceutical industry scams Mr. Alexander Oshmyansky presents Cost Plus Drug Company's innovative pricing model to reduce medication costs.

Alexander Oshmyansky reveals how his company is revolutionizing drug pricing and fighting against pharmaceutical industry scams to make medications affordable for all.

Learn more here!

#LA #CitizenPortal #DrugPricingReform #HealthcareTransparency #LouisianaPharmacy #PatientAccess

Vermont legislators push for transparency in 340B drug pricing practices Legislators advocate for clearer reporting on hospital revenues from 340B program in Vermont.

Vermont lawmakers are demanding transparency in the 340B drug pricing program, questioning who really bears the financial burden of discounted medications.

Read the full story!

#VT #HealthcareTransparency #DrugPricingReform #CitizenPortal #PatientBurden #VermontHealthcare

Connecticut prepares for Canadian drug importation program effective October 2027 Connecticut plans Canadian drug importation regulations to enhance consumer protection and oversight.

Connecticut lawmakers are on the verge of a groundbreaking decision that could drastically reduce prescription costs by allowing drug imports from Canada—will safety concerns derail this potential healthcare revolution?

Click to read more!

#CT #CitizenPortal #DrugPricingReform

Minnesota amends drug reporting requirements for wholesale distributors effective January 2024 Minnesota updates drug reporting mandates for wholesale distributors starting January 2024.

A groundbreaking bill in Minnesota aims to revolutionize the pharmaceutical supply chain by demanding transparency that could reshape drug pricing and accessibility for millions.

Learn more here

#MN #DrugPricingReform #PharmaceuticalTransparency #CitizenPortal #HealthcareAccessibility

New bill mandates transparency in pharmacy benefit management pricing and rebates Legislation requires detailed disclosure of pharmacy pricing and rebate information by managers

Nevada's groundbreaking Senate Bill 316 could revolutionize drug pricing by forcing pharmacy benefit managers to reveal hidden costs and rebates, promising greater transparency for consumers.

Get the details!

#NV #CitizenPortal #ConsumerEmpowerment #NevadaPharmaceuticals #DrugPricingReform

Legislature enacts HB 740 to enhance pharmacy pricing transparency and oversight HB 740 mandates regular updates and accessibility of drug pricing for pharmacies

Montana is set to revolutionize healthcare with House Bill 740, pushing for unprecedented transparency in pharmacy pricing that could transform how residents access their medications.

Click to read more!

#MT #HealthcareTransparency #PatientEmpowerment #DrugPricingReform #MontanaPharmacy

Illinois Board establishes upper payment limits aligned with Medicare drug pricing Illinois Board sets prescription drug payment limits based on Medicare Maximum Fair Price.

Illinois is on the brink of a groundbreaking legislative change that could redefine prescription drug pricing and access for its residents.

Click to read more!

#IL #DrugPricingReform #CitizenPortal #HealthcareAccess

Thank you ‪@mcuban.bsky.social‬ for your leadership in driving down drug prices and fighting healthcare misinformation. Your efforts are making a difference in improving access and truth in healthcare for Americans. Keep leading the way! #HealthEquity #FightMisinformation #DrugPricingReform